<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Seventeen patients with therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>/<z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) were examined for aberrant p15 gene methylation by methylation-specific polymerase chain reaction </plain></SENT>
<SENT sid="1" pm="."><plain>Ten patients (58%) showed p15 methylation, which was significantly related to <z:mp ids='MP_0004026'>monosomy</z:mp>/deletion of chromosome 7q, but not to antecedent chemotherapy, blast count, leukaemic evolution or survival </plain></SENT>
<SENT sid="2" pm="."><plain>In three of six patients with marrow samples obtained prior to the diagnosis of t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, p15 methylation predated disease development by up to 2 years </plain></SENT>
<SENT sid="3" pm="."><plain>Bone marrow transplantation led to the disappearance of p15 methylation in one patient </plain></SENT>
<SENT sid="4" pm="."><plain>These results showed that p15 methylation was an early event in the evolution of some t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients </plain></SENT>
</text></document>